MktsMarkets

Forte Biosciences, Inc.
NASDAQ: FBRXKey statistics
FBRX News
Stories mentioning FBRX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 22,439 | 24,571 | 18,383 | 11,579 | 16,124 | 7,351 | 8,629 | 12,818 |
| Operating Income (Loss) | (22,439) | (24,571) | (18,383) | (11,579) | (16,124) | (7,351) | (8,629) | (12,818) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 676.00 | (1,895) | 701.00 | 330.00 | 468.00 | (1,118) | 237.00 | 307.00 |
| Pretax Income | (21,763) | (15,656) | ||||||
| Tax Provision | 373.00 | 0.00 | ||||||
| Net Income (Loss) | (22,136) | (24,788) | (17,682) | (11,249) | (15,656) | (7,155) | (8,392) | (12,511) |
| Earnings Per Share (Basic) | (1.24) | (1.39) | (0.99) | (0.96) | (1.37) | 3.18 | (4.54) | (6.78) |
| Earnings Per Share (Diluted) | (1.24) | (1.39) | (0.99) | (0.96) | (1.37) | 3.18 | (4.54) | (6.78) |
| Weighted Average Shares Outstanding (Basic) | ||||||||
| Weighted Average Shares Outstanding (Diluted) | ||||||||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About FBRX
Forte Biosciences, Inc. (NASDAQ: FBRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol FBRX. It last traded at $0.0000 (Dec 31, 1969, 7:00 PM ET), up 0.0% on the day. That gives Forte Biosciences a market capitalisation of $1.6B.
Over the past 52 weeks FBRX has traded between $12.89 and $77.20.
For the quarter ended Mar 31, 2026 it reported a net loss of $22.1M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$22.1M |
| Dec 31, 2025 | — | -$24.8M |
| Sep 30, 2025 | — | -$17.7M |
| Jun 30, 2025 | — | -$11.2M |
From Forte Biosciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…